Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

NEWS

Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile
Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. ("Oramed"), are expected to participate in the $50 million convertible note offering, which is expected to close on or about October 7, 2024.The offering involves a refinancing and restructuring of existing debt and is expected to position Scilex for sustainable, long-term growth, as part of its multi-year plan to transform into a potential global and leading non-opioid pain management company.Scilex will receive from Oramed in consideration for the newly issued convertible note issued to Oramed an exchange and reduction of the principal balance under the Company's existing Senior Secured Promissory Note with Oramed (the "Oramed Note").Over the past 12 months, Scilex has aggressively addressed and restructured the debt on our balance sheet with payments of more than $80 million.The new financing will allow Scilex to retire the revolving facility with eCapital Healthcare Corp. in its entirety.As previously announced, on June 11, 2024, Scilex has successfully eliminated a $10.0 million loan with FSF 33433 LLC.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
Translate
Report
7808 Views
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2478Followers
107Following
27KVisitors
Follow